Gain	B:C0026882
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	B:C1419864
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	B:C0085612
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	B:C1833334
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	B:C0004238
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	B:C0026882
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	B:C1419864
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	B:C0017337
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	B:C0018787
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	B:C0037492
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	O
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

Gain	O
-	I:C0026882
of	I:C0026882
-	I:C0026882
function	I:C0026882
mutation	I:C0026882
in	O
SCN5A	O
causes	O
ventricular	O
arrhythmias	I:C0085612
and	O
early	O
onset	I:C1833334
atrial	O
fibrillation	I:C0004238
Mutations	O
in	O
SCN5A	O
,	O
the	O
gene	O
encoding	O
the	O
α-subunit	O
of	O
the	O
cardiac	O
sodium	O
channel	I:C0037492
(	I:C0037492
NaV1.5	I:C0037492
)	I:C0037492
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	B:C0003811
arrhythmia	I:C0003811
disorders	I:C0003811
.	O

The	O
purpose	O
of	O
this	O
study	B:C2603343
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
Dutch	O
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	O
arrhythmias	I:C0085612
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	O
function	I:C0232164
and	O
early	O
onset	I:C1833334
(	O
<	O
55	O
years	O
)	O
atrial	O
fibrillation	I:C0004238
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
Dutch	B:C0013331
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	O
arrhythmias	I:C0085612
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	O
function	I:C0232164
and	O
early	O
onset	I:C1833334
(	O
<	O
55	O
years	O
)	O
atrial	O
fibrillation	I:C0004238
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
Dutch	O
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	B:C0085612
arrhythmias	I:C0085612
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	O
function	I:C0232164
and	O
early	O
onset	I:C1833334
(	O
<	O
55	O
years	O
)	O
atrial	O
fibrillation	I:C0004238
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
Dutch	O
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	O
arrhythmias	I:C0085612
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	B:C0232164
function	I:C0232164
and	O
early	O
onset	I:C1833334
(	O
<	O
55	O
years	O
)	O
atrial	O
fibrillation	I:C0004238
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
Dutch	O
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	O
arrhythmias	I:C0085612
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	O
function	I:C0232164
and	O
early	B:C1833334
onset	I:C1833334
(	O
<	O
55	O
years	O
)	O
atrial	O
fibrillation	I:C0004238
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
Dutch	O
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	O
arrhythmias	I:C0085612
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	O
function	I:C0232164
and	O
early	O
onset	I:C1833334
(	O
<	O
55	O
years	O
)	O
atrial	B:C0004238
fibrillation	I:C0004238
.	O

We	O
performed	O
next	O
generation	O
sequencing	B:C0162326
in	O
the	O
proband	O
of	O
a	O
two	O
-	O
generation	O
Dutch	O
family	O
and	O
demonstrated	O
a	O
novel	O
missense	O
mutation	I:C0599155
in	O
SCN5A	O
-	I:C1419864
(	I:C1419864
p.	I:C1419864
M1851V	I:C1419864
)	I:C1419864
which	O
co-segregated	O
with	O
the	O
clinical	O
phenotype	O
in	O
the	O
family	O
.	O

We	O
performed	O
next	O
generation	O
sequencing	O
in	O
the	O
proband	O
of	O
a	O
two	O
-	O
generation	O
Dutch	B:C0013331
family	O
and	O
demonstrated	O
a	O
novel	O
missense	O
mutation	I:C0599155
in	O
SCN5A	O
-	I:C1419864
(	I:C1419864
p.	I:C1419864
M1851V	I:C1419864
)	I:C1419864
which	O
co-segregated	O
with	O
the	O
clinical	O
phenotype	O
in	O
the	O
family	O
.	O

We	O
performed	O
next	O
generation	O
sequencing	O
in	O
the	O
proband	O
of	O
a	O
two	O
-	O
generation	O
Dutch	O
family	O
and	O
demonstrated	O
a	O
novel	O
missense	B:C0599155
mutation	I:C0599155
in	O
SCN5A	O
-	I:C1419864
(	I:C1419864
p.	I:C1419864
M1851V	I:C1419864
)	I:C1419864
which	O
co-segregated	O
with	O
the	O
clinical	O
phenotype	O
in	O
the	O
family	O
.	O

We	O
performed	O
next	O
generation	O
sequencing	O
in	O
the	O
proband	O
of	O
a	O
two	O
-	O
generation	O
Dutch	O
family	O
and	O
demonstrated	O
a	O
novel	O
missense	O
mutation	I:C0599155
in	O
SCN5A	B:C1419864
-	I:C1419864
(	I:C1419864
p.	I:C1419864
M1851V	I:C1419864
)	I:C1419864
which	O
co-segregated	O
with	O
the	O
clinical	O
phenotype	O
in	O
the	O
family	O
.	O

We	O
functionally	O
evaluated	O
the	O
putative	O
genetic	O
defect	O
by	O
patch	O
clamp	O
electrophysiological	O
studies	O
in	O
human	O
embryonic	O
kidney	B:C0553257
cells	I:C0553257
transfected	O
with	O
mutant	O
or	O
wild	O
-	I:C1419864
type	I:C1419864
Nav1.5	I:C1419864
.	O

We	O
functionally	O
evaluated	O
the	O
putative	O
genetic	O
defect	O
by	O
patch	O
clamp	O
electrophysiological	O
studies	O
in	O
human	O
embryonic	O
kidney	O
cells	I:C0553257
transfected	B:C0040669
with	O
mutant	O
or	O
wild	O
-	I:C1419864
type	I:C1419864
Nav1.5	I:C1419864
.	O

We	O
functionally	O
evaluated	O
the	O
putative	O
genetic	O
defect	O
by	O
patch	O
clamp	O
electrophysiological	O
studies	O
in	O
human	O
embryonic	O
kidney	O
cells	I:C0553257
transfected	O
with	O
mutant	B:C0596988
or	O
wild	O
-	I:C1419864
type	I:C1419864
Nav1.5	I:C1419864
.	O

We	O
functionally	O
evaluated	O
the	O
putative	O
genetic	O
defect	O
by	O
patch	O
clamp	O
electrophysiological	O
studies	O
in	O
human	O
embryonic	O
kidney	O
cells	I:C0553257
transfected	O
with	O
mutant	O
or	O
wild	B:C1419864
-	I:C1419864
type	I:C1419864
Nav1.5	I:C1419864
.	O

The	O
current	O
inactivation	O
was	O
slower	O
and	O
recovery	O
from	O
inactivation	O
was	O
faster	O
in	O
SCN5A	B:C0037492
-	I:C0037492
M1851V	I:C0037492
channels	I:C0037492
.	O

The	O
voltage	O
dependence	O
of	O
inactivation	O
was	O
shifted	O
towards	O
more	O
positive	B:C1446409
potentials	O
and	O
consequently	O
,	O
a	O
larger	O
TTX	O
-	O
sensitive	O
window	O
current	O
was	O
observed	O
in	O
SCN5A	O
-	I:C0037492
M1851V	I:C0037492
channels	I:C0037492
.	O

The	O
voltage	O
dependence	O
of	O
inactivation	O
was	O
shifted	O
towards	O
more	O
positive	O
potentials	O
and	O
consequently	O
,	O
a	O
larger	O
TTX	B:C0039705
-	O
sensitive	O
window	O
current	O
was	O
observed	O
in	O
SCN5A	O
-	I:C0037492
M1851V	I:C0037492
channels	I:C0037492
.	O

The	O
voltage	O
dependence	O
of	O
inactivation	O
was	O
shifted	O
towards	O
more	O
positive	O
potentials	O
and	O
consequently	O
,	O
a	O
larger	O
TTX	O
-	O
sensitive	O
window	O
current	O
was	O
observed	O
in	O
SCN5A	B:C0037492
-	I:C0037492
M1851V	I:C0037492
channels	I:C0037492
.	O

Furthermore	O
,	O
a	O
higher	O
upstroke	O
velocity	O
was	O
observed	O
for	O
the	O
SCN5A	B:C0037492
-	I:C0037492
M1851V	I:C0037492
channels	I:C0037492
,	O
while	O
the	O
depolarization	O
voltage	O
was	O
more	O
negative	O
,	O
both	O
indicating	O
increased	O
excitability	O
.	O

Furthermore	O
,	O
a	O
higher	O
upstroke	O
velocity	O
was	O
observed	O
for	O
the	O
SCN5A	O
-	I:C0037492
M1851V	I:C0037492
channels	I:C0037492
,	O
while	O
the	O
depolarization	O
voltage	O
was	O
more	O
negative	B:C0205160
,	O
both	O
indicating	O
increased	O
excitability	O
.	O

This	O
mutation	B:C0026882
leads	O
to	O
a	O
gain	O
-	O
of	O
-	O
function	O
mechanism	O
based	O
on	O
increased	O
channel	O
availability	O
and	O
increased	O
window	O
current	O
,	O
fitting	O
the	O
observed	O
clinical	O
phenotype	O
of	O
(	O
likely	O
adrenergic	O
-	O
induced	O
)	O
ventricular	O
arrhythmias	I:C0085612
and	O
atrial	O
fibrillation	I:C0004238
.	O

This	O
mutation	O
leads	O
to	O
a	O
gain	O
-	O
of	O
-	O
function	O
mechanism	O
based	O
on	O
increased	O
channel	B:C0037492
availability	O
and	O
increased	O
window	O
current	O
,	O
fitting	O
the	O
observed	O
clinical	O
phenotype	O
of	O
(	O
likely	O
adrenergic	O
-	O
induced	O
)	O
ventricular	O
arrhythmias	I:C0085612
and	O
atrial	O
fibrillation	I:C0004238
.	O

This	O
mutation	O
leads	O
to	O
a	O
gain	O
-	O
of	O
-	O
function	O
mechanism	O
based	O
on	O
increased	O
channel	O
availability	O
and	O
increased	O
window	O
current	O
,	O
fitting	O
the	O
observed	O
clinical	O
phenotype	O
of	O
(	O
likely	O
adrenergic	O
-	O
induced	O
)	O
ventricular	B:C0085612
arrhythmias	I:C0085612
and	O
atrial	O
fibrillation	I:C0004238
.	O

This	O
mutation	O
leads	O
to	O
a	O
gain	O
-	O
of	O
-	O
function	O
mechanism	O
based	O
on	O
increased	O
channel	O
availability	O
and	O
increased	O
window	O
current	O
,	O
fitting	O
the	O
observed	O
clinical	O
phenotype	O
of	O
(	O
likely	O
adrenergic	O
-	O
induced	O
)	O
ventricular	O
arrhythmias	I:C0085612
and	O
atrial	B:C0004238
fibrillation	I:C0004238
.	O

These	O
findings	B:C0243095
further	O
expand	O
the	O
range	O
of	O
cardiac	O
arrhythmias	I:C0003811
associated	O
with	O
mutations	O
in	O
SCN5A	O
.	O

These	O
findings	O
further	O
expand	O
the	O
range	O
of	O
cardiac	B:C0003811
arrhythmias	I:C0003811
associated	O
with	O
mutations	O
in	O
SCN5A	O
.	O

These	O
findings	O
further	O
expand	O
the	O
range	O
of	O
cardiac	O
arrhythmias	I:C0003811
associated	O
with	O
mutations	B:C0026882
in	O
SCN5A	O
.	O

These	O
findings	O
further	O
expand	O
the	O
range	O
of	O
cardiac	O
arrhythmias	I:C0003811
associated	O
with	O
mutations	O
in	O
SCN5A	B:C1419864
.	O

